Back to Search Start Over

A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator.

Authors :
Athukoralage JS
Graham S
Grüschow S
Rouillon C
White MF
Source :
Journal of molecular biology [J Mol Biol] 2019 Jul 12; Vol. 431 (15), pp. 2894-2899. Date of Electronic Publication: 2019 May 06.
Publication Year :
2019

Abstract

Cyclic oligoadenylate (cOA) secondary messengers are generated by type III CRISPR systems in response to viral infection. cOA allosterically activates the CRISPR ancillary ribonucleases Csx1/Csm6, which degrade RNA non-specifically using a HEPN (Higher Eukaryotes and Prokaryotes, Nucleotide binding) active site. This provides effective immunity but can also lead to growth arrest in infected cells, necessitating a means to deactivate the ribonuclease once viral infection has been cleared. In the crenarchaea, dedicated ring nucleases degrade cA <subscript>4</subscript> (cOA consisting of 4 AMP units), but the equivalent enzyme has not been identified in bacteria. We demonstrate that, in Thermus thermophilus HB8, the uncharacterized protein TTHB144 is a cA <subscript>4</subscript> -activated HEPN ribonuclease that also degrades its activator. TTHB144 binds and degrades cA <subscript>4</subscript> at an N-terminal CARF (CRISPR-associated Rossman fold) domain. The two activities can be separated by site-directed mutagenesis. TTHB144 is thus the first example of a self-limiting CRISPR ribonuclease.<br /> (Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.)

Details

Language :
English
ISSN :
1089-8638
Volume :
431
Issue :
15
Database :
MEDLINE
Journal :
Journal of molecular biology
Publication Type :
Academic Journal
Accession number :
31071326
Full Text :
https://doi.org/10.1016/j.jmb.2019.04.041